Healthcare provider profile · identity verified

Kiritkumar D Patel, MD

Internal Medicine · ST PETERSBURG, FL · NPI 1346356748

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	566	170
Lisinopril	Lisinopril	456	138
Amlodipine Besylate	Amlodipine Besylate	432	132
Alprazolam	Alprazolam	297	46
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	292	47
Levothyroxine Sodium	Levothyroxine Sodium	289	78
Losartan Potassium	Losartan Potassium	285	79
Metformin Hcl	Metformin Hcl	228	70
Gabapentin	Gabapentin	185	57
Simvastatin	Simvastatin	180	48
Pantoprazole Sodium	Pantoprazole Sodium	175	59
Albuterol Sulfate Hfa	Albuterol Sulfate	157	49
Omeprazole	Omeprazole	157	46
Metoprolol Tartrate	Metoprolol Tartrate	142	41
Tamsulosin Hcl	Tamsulosin Hcl	133	38
Furosemide	Furosemide	126	35
Carvedilol	Carvedilol	125	37
Hydrochlorothiazide	Hydrochlorothiazide	120	34
Trazodone Hcl	Trazodone Hcl	107	29
Citalopram Hbr	Citalopram Hydrobromide	101	26
Meloxicam	Meloxicam	101	35
Eliquis	Apixaban	98	23
Tramadol Hcl	Tramadol Hcl	93	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	92	16
Azithromycin	Azithromycin	85	75
Clopidogrel	Clopidogrel Bisulfate	85	23
Nifedipine Er	Nifedipine	82	23
Prednisone	Prednisone	81	50
Hydralazine Hcl	Hydralazine Hcl	80	22
Rosuvastatin Calcium	Rosuvastatin Calcium	78	25
Sertraline Hcl	Sertraline Hcl	76	21
Famotidine	Famotidine	74	24
Pravastatin Sodium	Pravastatin Sodium	71	21
Zolpidem Tartrate	Zolpidem Tartrate	70	suppressed
Temazepam	Temazepam	68	11
Metoprolol Succinate	Metoprolol Succinate	67	19
Baclofen	Baclofen	62	13
Jardiance	Empagliflozin	58	14
Glipizide	Glipizide	51	15
Cephalexin	Cephalexin	48	34
Atenolol	Atenolol	47	14
Fluticasone Propionate	Fluticasone Propionate	47	15
Potassium Chloride	Potassium Chloride	44	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	34
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	12
Montelukast Sodium	Montelukast Sodium	42	15
Escitalopram Oxalate	Escitalopram Oxalate	40	13
Allopurinol	Allopurinol	37	11
Januvia	Sitagliptin Phosphate	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	36	suppressed
Ibuprofen	Ibuprofen	33	12
Sildenafil Citrate	Sildenafil Citrate	33	suppressed
Finasteride	Finasteride	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	12
Glimepiride	Glimepiride	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	11
Metformin Hcl Er	Metformin Hcl	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	14
Clonidine Hcl	Clonidine Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	16
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Ramipril	Ramipril	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Amoxicillin	Amoxicillin	20	14
Cefuroxime	Cefuroxime Axetil	20	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Topiramate	Topiramate	20	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Nitroglycerin	Nitroglycerin	19	11
Doxycycline Hyclate	Doxycycline Hyclate	18	14
Farxiga	Dapagliflozin Propanediol	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	17	suppressed
Valsartan	Valsartan	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	11
Carbamazepine	Carbamazepine	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	12
Tadalafil	Tadalafil	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Metronidazole	Metronidazole	14	13
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Estradiol	Estradiol	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Metolazone	Metolazone	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error